Clinical Practice Session
Glomerulonephritis in Systemic Diseases: Emphasis on Emerging Therapies and Prognosis
November 04, 2022 | 02:00 PM - 04:00 PM
Location: W415 Valencia, Orange County Convention Center, West Building
Session Description
For decades, systemic diseases characterized by glomerular and other vascular involvement have been treated primarily with corticosteroids and other highly nonspecific immunosuppressive agents. However, an increased understanding of the pathogenesis of these diseases has led to newer treatment approaches, some currently in use and others in development and in clinical trials. This session focuses on such approaches in several systemic diseases that frequently manifest as glomerulonephritis (GN) and vasculitis.
Support is provided by an educational grant from Travere Therapeutics, Inc.
Learning Objective(s)
- Discuss new findings on clinical-pathologic correlations in and therapeutic approaches to nephritis in IgA vasculitis
- Describe current and emerging therapeutic approaches to ANCA GN and vasculitis and to cryoglobulinemic GN and vasculitis based on pathogenic insights
- Summarize new and emerging treatment options for patients with lupus nephritis
Learning Pathway(s)
- Glomerular Diseases
Moderators
- Isabelle Ayoub, MD, MPH, FASN
- Dana Rizk, MD
Presentations
- IgA Vasculitis Nephritis: New Insights into Prognosis and Treatment from a Large International Study
02:00 PM - 02:30 PM
Evangeline Pillebout, MD, PhD
- Pathogenesis-Based Treatment Approaches to ANCA Glomerulonephritis and Vasculitis
02:30 PM - 03:00 PM
David R.W. Jayne, MBChB, MD
- Current Treatment of Cryoglobulinemic Glomerulonephritis and Vasculitis
03:00 PM - 03:30 PM
David Saadoun, MD, MS, MSc, PhD
- Treatment of Lupus Nephritis: Beyond the Usual Suspects
03:30 PM - 04:00 PM
Liz Lightstone, MBBS, PhD
